Monoclonal Antibody News and Research

RSS
Monoclonal antibodies (MAbs) are produced from a single B cell clone and can bind to a single type of antigen binding site. MAbs are homogenous antibodies that cannot form lattices with monomeric proteins as they can bind to only a single epitope on the antigen. Developed in the 1970s, MAbs can be produced against any given substance. Thus they can be used to detect and purify any substance of interest. This has made MAbs a powerful tool of molecular biology, biochemistry, and medicine.
Ocrelizumab provides superior control of multiple sclerosis relapses compared to other therapies

Ocrelizumab provides superior control of multiple sclerosis relapses compared to other therapies

New microfluidic-based biosensing platform helps track live antibody secretion dynamics

New microfluidic-based biosensing platform helps track live antibody secretion dynamics

Experts call for coordinated global action to make the most of Alzheimer’s treatments

Experts call for coordinated global action to make the most of Alzheimer’s treatments

Novel method accurately identifies therapeutic antibodies to treat infectious diseases

Novel method accurately identifies therapeutic antibodies to treat infectious diseases

BioDlink fast-tracks global growth with bevacizumab launch in Colombia and Pakistan

BioDlink fast-tracks global growth with bevacizumab launch in Colombia and Pakistan

Single antibody causes a rare but dangerous reaction to widely-used blood thinner

Single antibody causes a rare but dangerous reaction to widely-used blood thinner

New global consensus offers hope for women with inflammatory bowel disease during pregnancy

New global consensus offers hope for women with inflammatory bowel disease during pregnancy

Qureight's AI 3D imaging platform to support Calluna Pharma's Phase 2 AURORA study of CAL101 in idiopathic pulmonary fibrosis (IPF)

Qureight's AI 3D imaging platform to support Calluna Pharma's Phase 2 AURORA study of CAL101 in idiopathic pulmonary fibrosis (IPF)

Do GLP-1 drugs shrink your muscles? New study explains the risks and what to do

Do GLP-1 drugs shrink your muscles? New study explains the risks and what to do

Strategic tips for early-stage animal health companies facing regulatory challenges

Strategic tips for early-stage animal health companies facing regulatory challenges

Breakthrough in protein drug delivery could replace lengthy IV infusions

Breakthrough in protein drug delivery could replace lengthy IV infusions

Researchers find plasma donors with broad malaria protection

Researchers find plasma donors with broad malaria protection

Missing messenger RNA fragments unlock new immunotherapy targets in pediatric brain tumors

Missing messenger RNA fragments unlock new immunotherapy targets in pediatric brain tumors

Researchers find CFI deficiency alarmingly high in old order Amish

Researchers find CFI deficiency alarmingly high in old order Amish

Adding MET inhibitor enhances immune response against small cell lung tumors

Adding MET inhibitor enhances immune response against small cell lung tumors

Children show delayed exposure to respiratory viruses after COVID restrictions

Children show delayed exposure to respiratory viruses after COVID restrictions

Different anti-PD-L1 antibodies show varied results in tumor growth inhibition

Different anti-PD-L1 antibodies show varied results in tumor growth inhibition

Muscle loss from GLP-1 drugs could undermine long-term health

Muscle loss from GLP-1 drugs could undermine long-term health

New mRNA vaccine strategy awakens immune system to fight cancer

New mRNA vaccine strategy awakens immune system to fight cancer

Research highlights guselkumab's impact on Crohn's endoscopic healing

Research highlights guselkumab's impact on Crohn's endoscopic healing

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.